Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
10.1096/fj.202001507RR 116 NishimuraR.ShirasakiT.TsuchiyaK.MiyakeY.WatanabeY.HibiyaS.et al (2019)
What the Phase 2 Trial Data Shows According to data reviewed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), understanding clinical trial parameters is essential when setting expectations for any weight management medication
10.1177/0269881108091584 J Psychopharmacol
We found that touch neuron-specific overexpression of WAH-1, the ortholog of human AIFM1 and FSP1 (aka AIFM2), inhibited ML162-induced axonal fusion (Fig
US$ 25.90
US$ 24.70
US$ 22.70
US$ 22.29
